Cargando…

Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments—a systematic review

BACKGROUND: The introduction of immunotherapy in the treatment of non-small cell lung cancer (NSCLC) has resulted in a radical change in patients’ treatment responses and survival rates. The increased percentage of long survivors, improved toxicity profiles compared to chemotherapy, and the possible...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olivares-Hernández, Alejandro, González del Portillo, Elísabet, Tamayo-Velasco, Álvaro, Figuero-Pérez, Luis, Zhilina-Zhilina, Svetlana, Fonseca-Sánchez, Emilio, Miramontes-González, José Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477621/ https://www.ncbi.nlm.nih.gov/pubmed/37675322 http://dx.doi.org/10.21037/atm-22-4218

Ejemplares similares

Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies
por: Olivares-Hernández, Alejandro, et al.
Publicado: (2021)

Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors
por: Olivares-Hernández, Alejandro, et al.
Publicado: (2021)

Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
por: Toribio-García, Irene, et al.
Publicado: (2023)

The relationship between PARP inhibitors with the relapse and leukemisation of lymphomas: a case report
por: Navalón-Jiménez, Marta, et al.
Publicado: (2023)

Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications
por: Olivares-Hernández, Alejandro, et al.
Publicado: (2021)

Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis
por: Olivares-Hernández, Alejandro, et al.
Publicado: (2022)

Structural transitions in the transcription elongation complexes of bacterial RNA polymerase during σ-dependent pausing
por: Zhilina, Ekaterina, et al.
Publicado: (2012)

Halanaerobium polyolivorans sp. nov.—A Novel Halophilic Alkalitolerant Bacterium Capable of Polyol Degradation: Physiological Properties and Genomic Insights
por: Boltyanskaya, Yulia, et al.
Publicado: (2023)

Aislamiento de Moraxella atlantae en la válvula nativa de un paciente con endocarditis infecciosa
por: Carbonell-Muñoz, Cristina, et al.
Publicado: (2018)

Synthesis of Mono- and Polyazole Hybrids Based on Polyfluoroflavones
por: Panova, Mariya A., et al.
Publicado: (2023)

Asociación del grupo sanguíneo A con mayor comorbilidad hospitalaria en pacientes infectados por SARS-CoV-2
por: Tamayo-Velasco, Álvaro, et al.
Publicado: (2022)

Association of blood group A with hospital comorbidity in patients infected by SARS-CoV-2()
por: Tamayo-Velasco, Álvaro, et al.
Publicado: (2022)

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
por: Cai, Xin, et al.
Publicado: (2021)

Diffuse Alveolar Hemorrhage Associated with Epithelioid Angiosarcoma of the Lung: A Challenging Diagnosis
por: Wuest, Felix, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective
por: Lavacchi, Daniele, et al.
Publicado: (2020)

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer
por: Seesaha, Poshita-Kumari, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives
por: Rebuzzi, Sara Elena, et al.
Publicado: (2022)

Synthesis of Heteroannulated Indolopyrazines through Domino N–H Palladium-Catalyzed/Metal-Free Oxidative C–H Bond Activation
por: Kvashnin, Yuriy A., et al.
Publicado: (2020)

Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma
por: Apostolidis, John, et al.
Publicado: (2020)

Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
por: Hotta, Katsuyuki, et al.
Publicado: (2020)

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
por: Yi, Huimei, et al.
Publicado: (2021)

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives
por: Liu, Zherui, et al.
Publicado: (2023)

Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic
por: Tamayo-Velasco, Álvaro, et al.
Publicado: (2022)

Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors
por: Olivares-Hernández, Alejandro, et al.
Publicado: (2021)

Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

Combination of current and new electrocardiographic-based criteria: a novel score for the discrimination of left bundle branch capture
por: Briongos-Figuero, Sem, et al.
Publicado: (2023)

Enzyme Therapy: Current Challenges and Future Perspectives
por: de la Fuente, Miguel, et al.
Publicado: (2021)

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab()
por: Figuero-Pérez, Luis, et al.
Publicado: (2021)

Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab
por: Figuero-Pérez, Luis, et al.
Publicado: (2021)

The virtual cell based assay: Current status and future perspectives
por: Graepel, Rabea, et al.
Publicado: (2017)

Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives
por: Zhang, Zhening, et al.
Publicado: (2020)

Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade
por: Gorzo, Alecsandra, et al.
Publicado: (2022)

Uso de anakinra en el tratamiento de la infección respiratoria grave por SARS-CoV-2
por: Figuero-Pérez, Luis, et al.
Publicado: (2023)

Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection()
por: Figuero-Pérez, Luis, et al.
Publicado: (2023)

Stakeholder Perspectives on the Current and Future of Additive Manufacturing in Healthcare
por: Villapún, Victor M., et al.
Publicado: (2022)

Transcatheter tricuspid valve interventions: Current status and future perspectives
por: Alperi, Alberto, et al.
Publicado: (2022)

I Can Not Wear My Sunglasses: An Unusual Sarcoidosis Presentation
por: Miramontes González, José Pablo, et al.
Publicado: (2017)

Glioblastoma Treatment: State-of-the-Art and Future Perspectives
por: Rodríguez-Camacho, Alejandro, et al.
Publicado: (2022)

Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors–Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment
por: Yoshikawa, Yoshie, et al.
Publicado: (2020)

DNA Damage and Repair in Atherosclerosis: Current Insights and Future Perspectives
por: Cervelli, Tiziana, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vhnratl63ge4ifmpehf0462mfc